Treatment of Refractory Mastocytic Enterocolitis with Budesonide
| Autor: | Sonia Mathew, Vaidehi Avadhani, Merin Kuruvilla |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Budesonide
medicine.medical_specialty medicine.diagnostic_test medicine.drug_class business.industry Gastroenterology medicine.disease Diarrhea Refractory Gastrointestinal disease Internal medicine Biopsy medicine Mast cell stabilizer medicine.symptom business Irritable bowel syndrome Mastocytic enterocolitis medicine.drug |
| Zdroj: | Journal of Gastrointestinal and Liver Diseases. 27:327-329 |
| ISSN: | 1842-1121 1841-8724 |
| DOI: | 10.15403/jgld.2014.1121.273.dha |
| Popis: | Mast cells (MCs) are being increasingly implicated as a possible contributor to symptoms in diarrhea predominant irritable bowel syndrome (IBS). The term “mastocytic enterocolitis” was proposed to describe an increase in mucosal MCs in patients with chronic diarrhea due to functional gastrointestinal disease (FGID). The efficacy of anti–MC mediator therapy (antihistamines and MC stabilizers) has been well documented in this setting. Here we describe the treatment with oral budesonide of mastocytic enterocolitis refractory to standard anti-MC therapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|